Stocktoria

MERIT MEDICAL SYSTEMS INC MMSI

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1954-09-16 · LEI

MERIT MEDICAL SYSTEMS INC (MMSI) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $1.5B at a 8.5% net margin.

Chart by TradingView
73/100
Stocktoria Quality Score · grade A
7/9
Piotroski F — financial health
4.93
Altman Z″ — distress risk · safe
Dividend yield · no dividend
-2.72
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 7 5 5 5 7 7 5 7 7 2016201720182019202020212022202320242025
Altman Z″
3.52 3.96 3.43 3.00 3.08 3.82 4.82 4.84 4.68 4.93 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$91.20 as of 2026-08-01 · +0.7% 1y
$63.06$91.2052-wk

Beneish M-score: -2.72 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$4.3B
P / E33.3×
Net margin 5y avg7.2%
Return on equity 5y avg7.2%
Beta0.53
Employees7,500

Analyst price target

$89.55 -1.8% vs last
· 11 analysts
target range $74.00 – $110.00 · median $85.00
5 strong buy · 4 buy · 2 hold
Recent analyst actions
DateFirmRating
2026-05-01Canaccord GenuityBuy (main)
2026-05-01JP MorganOverweight (main)
2026-05-01Wells FargoEqual-Weight (main)
2026-05-01NeedhamBuy (main)
2026-04-20Barrington ResearchOutperform (main)
2026-04-17Piper SandlerOverweight (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 90%
Net marginstronger than 76%
Return on equitystronger than 71%
Revenue growthstronger than 69%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 7/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.298
Retained earnings / assets0.307
EBIT / assets0.069
Equity / liabilities1.438

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MMSIMERIT MEDICAL SYSTEMS INC7/94.9333.3+11.8%
PENPenumbra Inc6/98.5970.1+17.5%
IARTINTEGRA LIFESCIENCES HOLDINGS CORP5/91.17+1.5%
HAEHAEMONETICS CORP7/92.8536.1-2%
EMBCEmbecta Corp.6/91.992.2-3.8%
TFXTELEFLEX INC5/93.56+17.2%
TNDMTANDEM DIABETES CARE INC3/9-3.04+7.9%

All Manufacturing companies →

About MERIT MEDICAL SYSTEMS INC

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

FAQ

Is MMSI financially healthy?

MERIT MEDICAL SYSTEMS INC's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does MMSI pay a dividend?

No, MERIT MEDICAL SYSTEMS INC does not currently pay a dividend.

How profitable is MMSI?

In FY2025, MERIT MEDICAL SYSTEMS INC had a net margin of 8.5% and a return on equity of 8.1%.

Is MMSI overvalued or undervalued?

MERIT MEDICAL SYSTEMS INC trades at about 42.8× trailing earnings — below its 10-year norm (10-year range 31.2×–364.2×, median 56.4×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for MMSI?

The average Wall-Street price target for MERIT MEDICAL SYSTEMS INC is $89.55, about 1.8% below the recent price, from 11 analysts.

Is MMSI a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on MERIT MEDICAL SYSTEMS INC: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 33.3×. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.